Flow cytometry tools for characterization of GMP cell products

Similar documents
Challenges for Flow Cytometry in Regulated Bioanalysis

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Technical Applications Track 2 Safety Testing for Cell Therapy Products: Requirements, Relevance, and New Technologies

Comparability for Advanced Therapy Medicinal Products. Christopher A Bravery

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

Regulatory considerations for manufacturing and testing of investigational chimeric antigen receptor (CAR) T-cell products

Challenges in receptor occupancy determination assays by flow cytometry in drug development

Quality of raw materials and manufacturing of advanced therapies. Fouad Atouf, Ph.D. Head, Global Biologics July 12, 2018

Fusion AE. Analytical Method Development And Method Validation

CQAs for C&GT Products to Enable Comparability Assessment. Ben Thompson Snr Director, Biopharmaceutical CMC RA GlaxoSmithKline

Challenges for Product Evaluation by Flow Cytometry for Cellular Therapy Product Processing Laboratories

Quality development considerations - Regulatory perspective

Case Study: Examples Relating to the Quality Control of Cell-based Products

Quality Control in Flow. Dr David Westerman Head of Haematopathology Peter MacCallum Cancer Centre

Cell Processing Workstation. In Situ Laser-Mediated Cell Purification and Processing

Application Note. Assay Portability on the BD FACSVerse System. Summary. Maria Jaimes, Yibing Wang, Catherine McIntyre, and Dev Mittar

FusionChrom. Analytical Method Development And Method Validation

Product Testing & Release. PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 4 th /5 th, 2006

CASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist

CyTOF 2. Mass Cytometry System

BD FACSMelody. Cell Sorter. The simple solution for consistent, quality results

Assessing and Controlling Potency of Vector and Drug Product for Chimeric Antigen Receptor T Cells

quantitate host cell DNA with high sensitivity and throughput resdnaseq Host Cell DNA Quantitation Systems: CHO, E.

Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.

ADCC Reporter Bioassay: A Novel, Bioluminescent Cell-Based Assay for Quantifying Fc Effector Function of Antibodies

ACCURACY THE FIRST TIME. Bring Your Esoteric Assays In-House Routinely SCIEX DIAGNOSTICS MASS SPECTROMETERS

Product Testing & Release. PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 10 th /11 th, 2007

CMC Writing for IND Applications. David H. McKenna, Jr., M.D. University of Minnesota PACT Web Seminar II July 14, 2005

Product testing and release criteria: The importance of analytical method development and validation, including potency assays

Manufacturing Challenges with Cell and Gene Therapy Products: A Health Canada Perspective

CyTOF 2 Mass Cytometry System

IsoFluxTM. System. The next generation of CTC Analysis is here

Hematopoietic Progenitor Cell Product Characterization

Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL

Flow cytometry within reach.

BD Multicolor CompBeads

Changes to a Potency Bioassay for Biotechnology Products: a Regulatory Perspective Kathleen A. Clouse, Ph.D., Director Division of Monoclonal Antibodi

Flow Cytometry SOP: Monocytes from Frozen Cells

Principles of flow cytometry: overview of flow cytometry and its uses for cell analysis and sorting. Shoreline Community College BIOL 288

Molecular Diagnosis Challenges & Solutions. Using Molecular Kits or Laboratory Developed Tests (Home Brew), Emphasis on Validation

WVU FLOW CYTOMETRY & SINGLE CELL CORE FACILITY

Flow Cytometric Preparation of CD34 + CD90 + Hematopoietic Stem Cells for Transplantation

WVU FLOW CYTOMETRY & SINGLE CELL CORE FACILITY

Analytical Procedures and Methods Validation for Drugs and Biologics

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology

bulk Great deals! orders! Save on all cytokines and Miltenyi Biotec s EOY12 United Kingdom instrument antibodies! starting kits and separators!

Ancillary Materials for Cell & Tissue Therapies Definitions, US Regulatory Approach, and USP s Risk-Tiered Approach

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

Flow Cytometry SOP: 14 color flow for immune activation, senescence, and exhaustion

Each question may have MULTIPLE correct answers. Select all that are correct.

Cytomics in Action: Cytokine Network Cytometry

Fusion Analytical Method Validation

Cancer inflammation research applications and products

Flow Cytometry Immune Activation SOP

Detection and Quantitation of Residual Host Cell DNA

PERFECT-COUNT MICROSPHERES

Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development

A previous ICCS Module entitled Instrument optimization - Adjusting PMT voltages and compensation 1 should be read as a prerequisite to this module.

Beth Hutchins, PhD PhRMA ICH Gene Therapy Discussion Group

Specialty Lab Services. Deep science at scale

Fusion Analytical Method Validation

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Flow Cytometry: Future & New Developments. BVAC/ABCA Workshop 5-6 May 2011, Mol, B. Dirk Van Bockstaele, Ph.D. Global Director Flow Cytometry

London, 11 October 2006 Doc. Ref. EMEA/CHMP/BWP/271475/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Incorporating New, Bright Fluorochromes into Multicolor Panel Design

Analytical Considerations for Potency Testing. Christopher A Bravery Cytotherapy, Volume 15 (Issue 1) January 2013 (p 9-19)

Polaris and Callisto: Advances in Cellular Biology. Jordan Moore Senior Field Applications Specialist

Replacing Analytical Methods for Release and Stability Testing CBER Perspective

Outsourcing and Partnering for Commercial Grade Manufacturing Frank Tufaro, Ph.D.

UCD Flow Cytometry Summer School Flow Cytometry: Principles & Practice

OUR MISSION OUR EXPERTISE OUR SERVICES

CMC Considerations for Stem Cell-based. Donald W. Fink, Jr., Ph.D.

ACCURACY THE FIRST TIME. Reliable testing with performance, productivity and value combined AB SCIEX 3200MD SERIES MASS SPECTROMETERS

Sheng Lin-Gibson, Ph.D.

Mass Cytometry Comprehensive Publications

Perspectives on Method Validation: Importance of Adequate Method Validation

Ligand Binding Assays: Summary and Consensus from the Bioanalytical Workshop (CC V)

GUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION

PCR SYSTEMS. a new era in high-productivity qpcr. Applied Biosystems ViiA 7 Real-Time PCR System

Regulatory Implications for Global Manufacturing Development of Regenerative Medicines

Challenges associated with supply to larger patients populations: Elements of the CTL019 experience

Cell Therapy Product Manufacturing Considerations. July 17, 2017 CMC Strategy Forum Mo Heidaran, Ph.D.

Flowcytometry Dirk Pacholsky

Application note. Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers.

THE FREEDOM TO DISCOVER BOND RX FULLY AUTOMATED IHC AND ISH AND EMERGING TESTS RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Quantification of Host Cell Protein Impurities Using the Agilent 1290 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System

Phase Appropriate Method Validation

Flow Cytometric Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE

Development, Optimization and Validation of Luminex based cytokine assays

Rapid Microbiological. PDA: A Global. Methods. Association. Gilberto Dalmaso Aseptic Processes Development Manager

Diagnostics in Oncology Mark Kockx MD, PhD

Specifications. February 19, 2015, TOKYO, JAPAN. Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Streamlined and Complete LC-MS Workflow for MAM

Start With the End in Mind A Diagnostic Company s Perspective on Companion Diagnostic Development. Paul Docherty PhD Relationship Management

2100 Bioanalyzer. Overview & News. Ralph Beneke Dec 2010

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

High-dimensional flow-cytometric analysis of human B-cell populations

Principles of Multicolor Panel Design BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.

Mass Cytometry: A new platform for single cell characterization Marie Iannone Biological Sciences Research Triangle Park, NC

Transcription:

Flow cytometry tools for characterization of GMP cell products Alexandra Rizzitelli, PhD Project manager Cell therapies Pty Ltd, Melbourne, Australia

What is product characterization? Identity (phenotype) Surface markers Gene expression Potency (efficacy) Cytokine release Killing assay Purity (contaminants) & impurity Endotoxins BSA FCS Other cells Safety (sterility) Mycoplasma Bacteria Virus Fungi Ensure product quality, specification, lot-to-lot consistency Complexity & heterogeneity 21 July 2016 Page 2

What is GMP? Defined manufacturing process Good Manufacturing Practices aims: quality in eachbatch of product during allstages of the manufacturing process TGA (Therapeutic Goods Administration) standards = control over the process Donor selection / screening/ collection Materials, equipment and reagents used Transport, storage and shelf life Labelling Tests performed: FIO # release 21 July 2016 Page 3

Identity Flow in GMP environment Multi-parametric cell surface /intracell staining (B, T cells, etc.) Gene expression (mrna, mirna, etc ) Viability Count Impurity Potency Intra-cellular cytokine production Killing assay Affordable / Quick / Accessible -> primary choice 21 July 2016 Page 4

Flow in GMP environment Multiple platform Instrument? Analyser or sorter? -> open system Reagents grade In Vitro Diagnostic (IVD) Research use only (RUO) Level of testing / specification (e.g Ab concentration) Flow in GMP = control of facility + instrument + material + reagents + method 21 July 2016 Page 5

Flow in GMP environment Evidences of: Staff training Procedure followed Records Control of material Defined analysis steps Facility / instrument: Temperature Humidity Cleaning Maintenance Performance (daily CST) 21 July 2016 Page 6

Validation of flow methods Validation is to demonstrate that the analytical method is suitable for its intended purpose ICH Guideline, validation of analytical procedures: text and methodology q2(r1) 2005 Validation characteristics: Specificity -> matrix interference Accuracy -> agreement with a conventional value -> NO universal reference for flow Precision repeatability :short time interval, intra-assay intermediate precision: within laboratory, different days, operators, instrument reproducibility : between laboratories Range -> upper, lower concentration Linearity -> within a range Detection Limits Quantification Limits Robustness -> unaffected by small, deliberate variations (time) Other to consider: Multisite standardisation Control/reference sample Sample preparation Analysis, gating strategy 21 July 2016 Page 7

Subjective analysis -Gating 21 July 2016 Page 8

Standardizing gating Finaket al. Nature scientific report Feb 2016 Human Immune Phenotyping Consortium (HIPC) 5 x Lyophilized 8-color Ab panel Lyophilized PBMC Cryopreserved PBMC 9 labs (Fortessaor LSR) Manual -at each lab Analysis Gating Manual - centralized Automated - centralized OpenCyto and FlowDensity 21 July 2016 Page 9

Standardizing gating Instruments standardized: Target values for PMTV Compensation beads lyophilized Findings Lyophilized cells slightly better than cryopreserved Manual centralized more reproducible than per-site manual gating Automated gating is as good as manual centralized gating -except for not well defined population (dim/rare) 21 July 2016 Page 10

OpenCyto/ FlowDensity Open Source packages using R language Series of written commands define gating strategy based on algorithm models 1 Ab panel -> 1 strategy -> 1 file saved Applicable to multiple experiment as long as same markers and fluorochromes are used in the sample 21 July 2016 Page 11

OpenCyto

OpenCyto 21 July 2016 Page 13

Automatic gating and GMP Strength: No subjectivity Increase reproducibility Audit Time / cost for large dataset Validation: Software (FDA, 21 CFR part 11) 21 July 2016 Page 14

Quantification of RNA expression Prime Flow (affimetrix) Fluorescent In Situ Hybridization (FISH) Fixed / permabilized cells A647 / a488 / a750 21 July 2016 Page 15

RNA expression Smart Flare (Merck Millipore) Endocytosis of gold nanoparticles Live cells Cy3 (a546) or Cy5 (a647) 21 July 2016 Page 16

RNA expression Advantages Potential for defining GMP cell product Minor sub-populations Activation status Potency Lineage restriction In-process quality control Specifications Inconvenients Limited to detection of 3 RNA per cell at one time GMP grade materials For information only Release criteria Assay validation 21 July 2016 Page 17

Mass cytometry -CyTOF TOF (Time-of-Flight) based on: Electric field with defined intensity and length Metal ions of different mass (isotopes) Detector Heavier ion = longer TOF Lanthanide elements (rare metal) Antibodies labels with metal isotopes 21 July 2016 Page 18

CyTOF Figure from Bendall et al. Science 2011 21 July 2016 Page 19

CyTOF Advantages No spectral overlap No auto-fluorescence Increase number of parameters (35) Quantitative Well defined phenotype: signature card / barcode Inconvenients No equivalent of SSC/FSC No cell recovery Low cell efficiency (80% cell lost) Slow acquisition (double time/flow) Limited commercially available labelled Ab GMP grade reagents/software 21 July 2016 Page 20

Conclusions GMP cell product characterization Well defined process New tools will help defined product Automatic gating RNA expression CyTOF signature card Quality improvement of cell-based therapies 21 July 2016 Page 21